Profile

Sarah L. Berga, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

37 Ratings
5 Comments
 

Sarah L. Berga, M.D.

Chair,
Professor,




Clinical Interests

Amenorrhea, Anovulation, Complex Hormonal Conditions, Gonadal Dysgenesis, Hyperprolactinemia, Infertility, Stress-induced Anovulation

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-6476
Department: 336-716-4594

Email: sberga@wakehealth.edu

Insurance Accepted »

Education & Training

  • B.A., University of Virginia, 1976
  • M.D., University of Virginia, 1980
  • Residency, Obstetrics & Gynecology, Massachusetts Gen Hosp, 1984
  • Fellowship, Obstetrics & Gynecology, University of California Sch o, 1986

Board Certifications

  • American Board of Obstetrics & Gynecology, Obstetrics & Gynecology
  • American Board of Obstetrics & Gynecology, Obstetrics & Gynecology, Reproductive Endocrinology/Infertility

NPI Number

  • 1124054218
Sarah L. Berga, M.D.

Doctor Rating

4.7 out of 5

37 Ratings
5 Comments
 

Sarah L. Berga, M.D.

Chair, Obstetrics & Gynecology
Professor, Obstetrics & Gynecology
Center for Comparative Medicine Research
Hypertension and Vascular Research Center
Office of Women in Medicine and Science
Translational Science Institute

Research Interests

hormones/cytokines/signalling, instrument development, medical technology/devices, model development, neurosciences/behavior, osteoporosis, women's health issues

Contact Information

Academic: 336-716-4594 | Department: 336-716-4594

Email: sberga@wakehealth.edu

Recent Publications

Shufelt C, Elboudwarej O, Johnson BD, Mehta P, Bittner V, Braunstein G, Berga S, Stanczyk F, Dwyer K, Merz CN. Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study. Menopause. 2016;23(2):150-157.

Ranganathan P, Kumar RG, Davis K, McCullough EH, Berga SL, Wagner AK. Longitudinal sex and stress hormone profiles among reproductive age and post-menopausal women after severe TBI: a case series analysis. Brain Inj. 2016;():.

Santarsieri M, Kumar RG, Kochanek PM, Berga S, Wagner AK. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury. Brain Behav Immun. 2015;45():15-27.

Yu J, Berga SL, Johnston-MacAnanny EB, Huang L, Sidell N, Bagchi IC, Bagchi MK, Taylor RN. Human endometrial stromal cell connexin (Cx)43 responds reversibly to hormone stimulation and withdrawal and regulates markers of angiogenesis and Mesenchymal-Epithelial Transition (MET) [abstract]. Reprod Sci. 2015;22(Suppl 1):81A.

Bender CM, Merriman JD, Gentry AL, Ahrendt GM, Berga SL, Brufsky AM, Casillo FE, Dailey MM, Erickson KI, Kratofil FM, McAuliffe PF, Rosenzweig MQ, Ryan CM, Sereika SM. Patterns of change in cognitive function with anastrozole therapy. Cancer. 2015;121(15):2627-2636.

Barton DJ, Kumar RG, McCullough EH, Galang G, Arenth PM, Berga SL, Wagner AK. Persistent hypogonadotropic hypogonadism in men after severe traumatic brain injury: temporal hormone profiles and outcome prediction. J Head Trauma Rehabil. 2015;():.

Wagner A, Kumar R, Conley Y, Kochanek P, Berga S. Multiple aromatization mechanisms influence mortality and CNS secondary injury profiles after severe TBI [abstract]. J Neurotrauma. 2015;32(12):A92.

Wagner A, Kumar R, Ritter A, Kochanek P, Berga S. Serum tumor necrosis factor-alpha association with mortality six months after TBI: mechanistic relationships with estradiol [abstract]. J Neurotrauma. 2015;32(12):A92-A93.

Santarsieri M, Niyonkuru C, McCullough EH, Dobos JA, Dixon CE, Berga SL, Wagner AK. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury. J Neurotrauma. 2014;31(8):699-712.

Bender C, Sereika S, Ryan C, Berga S. Are changes in reproductive hormone levels related to changes in cognitive function in women with breast cancer? [abstract]. Nurs Res. 2014;63(2):E58.

Steiner M, Miller V, Garovic V, Rich-Edwards J, Mallampalli M, Merz CNB, Berga S, Reckelhoff J, Taylor D, Wenger N, Ouyang P. Validating the need for uniform information on reproductive history for women in clinical cardiovascular studies and databases [abstract]. J Womens Health. 2014;23(4):14.

Yu J, Berga SL, Yalcinkaya T, Huang, L, Bagchi IC, Bagchi MK, Taylor RN. Gap junction protein connexin 43 is necessary and sufficient for pro-implantation phenotype in human endometrial stromal cells [abstract]. Reprod Sci. 2014;21(3 Suppl):413A-414A.

Yu J, Berga SL, Salinas A, Johnston-MacAnanny E, Taylor RN. Ovarian hormones modify cell cycle dynamics, apoptosis and telomere length in primary human endometrial stromal cells [abstract]. Reprod Sci. 2014;21(3 Suppl):414A.

Yu J, Berga SL, Zou W, Sun HY, Johnston-MacAnanny E, Yalcinkaya T, Sidell N, Bagchi IC, Bagchi MK, Taylor RN. Gap junction blockade induces apoptosis in human endometrial stromal cells. Mol Reprod Dev. 2014;81(7):666-675.

Constantine GD, Kagan R, Berga S, Graham S, Archer DF. Ospemifene improved the severity of vulvar and vaginal atrophy symptoms in postmenopausal women in phase 3 randomized, placebo-controlled trials [abstract]. Menopause. 2014;21(12):1332.

Stuart JJ, Bairey Merz CN, Berga SL, Miller VM, Ouyang P, Shufelt CL, Steiner M, Wenger NK, Rich-Edwards JW. Maternal recall of hypertensive disorders in pregnancy: a systematic review. J Womens Health. 2013;22(1):37-47.

Michopoulos V, Mancini F, Loucks TL, Berga SL. Neuroendocrine recovery initiated by cognitive behavioral therapy in women with functional hypothalamic amenorrhea: a randomized, controlled trial. Fertil Steril. 2013;99(7):2084-2091.

Archer DF, Autry A, Barbieri RL, Berek JS, Berga SL, Bernstein IM, Brodman M, Brown H, Buekens P, Bulun SE, Burkman RT, Campbell WA, Carson LF, Caughey AB, Chaudhuri G, Chelmow D, Chervenak F, Clarke-Pearson DL, et al. A statement on abortion by 100 professors of obstetrics: 40 years later. Am J Obstet Gynecol. 2013;88(4):568-576.

Berga SL. Profile of ospemifene in the breast. Reprod Sci. 2013;20(10):1130-1136.

Garringer JA, Niyonkuru C, McCullough EH, Loucks T, Dixon CE, Conley YP, Berga S, Wagner AK. Impact of aromatase genetic variation on hormone levels and global outcome after severe TBI. J Neurotrauma. 2013;30(16):1415-1425.

Michopoulos V, Embree M, Reding K, Sanchez MM, Toufexis D, Votaw JR, Voll RJ, Goodman MM, Rivier J, Wilson ME, Berga SL. CRH receptor antagonism reverses the effect of social subordination upon central GABAA receptor binding in estradiol-treated ovariectomized female rhesus monkeys. Neuroscience. 2013;250():300-308.

Bender CM, Sereika SM, Ryan CM, Brufsky AM, Puhalla S, Berga SL. Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer?. Menopause. 2013;20(9):922-929.

Francisco AMC, Yu J, Yalcinkaya T, Johnston-MacAnanny EB, Sidell N, Berga SL, Taylor RN. Estradiol and inflammatory cytokines induce neuroangiogenic responses in endometriosis stromal cells [abstract]. Reprod Sci. 2013;20(3 Suppl):149A.

Stephens SM, Pau FK, Yalcinkaya TM, May MC, Berga SL, Post MD, Appt SE, Polotsky AJ. Assessing the pulsatility of luteinizing hormone in female vervet monkeys (Chlorocebus aethiops sabaeus). Comp Med. 2013;63(5):432-438.

Franks S, Berga SL. Does PCOS have developmental origins?. Fertil Steril. 2012;97(1):2-6.

Berga S, Naftolin F. Neuroendocrine control of ovulation. Gynecol Endocrinol. 2012;28(Suppl 1):9-13.

Menon R, Yu J, Basanta-Henry P, Brou L, Berga SL, Fortunato SJ, Taylor RN. Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes. PLoS ONE. 2012;7(2):e31136.

Hoffman JB, Kaplan JR, Kinkead B, Berga SL, Wilson ME. Metabolic and reproductive consequences of the serotonin transporter promoter polymorphism (5-HTTLPR) in adult female rhesus monkeys (Macaca mulatta) [abstract]. Endocrine. 2007;31(2):202-211.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Obstetrics & Gynecology

Clinical Interests

Amenorrhea, Anovulation, Complex Hormonal Conditions, Gonadal Dysgenesis, Hyperprolactinemia, Infertility, Stress-induced Anovulation
Sarah L. Berga, M.D.

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.9
Time CP spent with patient
4.9
Wait time at clinic
3.8



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

12/31/2015

Dr. Berga is an amazing doctor that is incredibly thorough in her diagnosis. I would recommend her to anyone seeking a doctor!

12/10/2015

Wonderful *Dr. Berga.

11/11/2015

Outstanding care by an outstanding MD.

9/2/2015

Informative - answered questions - warm, sincere, interested.

6/9/2015

Open to our opinion, listened to where we were as a couple before giving input.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.